Overview

A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Status:
Completed

Trial end date:
2020-08-10

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to compare LY900014 to insulin lispro (Humalog) in participants with type 1 diabetes who are using an insulin pump and have high blood sugar after eating. For each participant, the study will last about two to nine weeks.

Phase:

Phase 1

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Insulin
Insulin Lispro
Insulin, Globin Zinc